Stocks and Investing Stocks and Investing
Thu, February 25, 2021
[ 12:00 AM ] - WOPRAI
Michael Phillips Maintained (AIG) at Buy with Increased Target to $52 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Nigel Dally Maintained (AFL) at Buy with Increased Target to $55 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Kligerman Maintained (AFL) at Hold with Increased Target to $48 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Berens Downgraded (ZYME) to Hold and Decreased Target to $41 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Brandon Nispel Maintained (WOW) at Buy with Increased Target to $20 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Ray Kwan Maintained (BTE) at Hold with Increased Target to $1.5 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Danielle Antalffy Maintained (VCEL) at Buy with Increased Target to $60 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Maintained (VCEL) at Stron .. y with Increased Target to $60 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
A.J. Rice Maintained (CCRN) at Hold with Increased Target to $11 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Carlos Laboy Maintained (CCU) at Hold with Increased Target to $19 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Cooper Maintained (CDNA) at Strong Buy with Decreased Target to $98 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Michael Wiederhorn Maintained (CHE) at Buy with Decreased Target to $580 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Daniel Kurnos Upgraded (TRUE) to Strong Buy and Held Target at $8 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Ju Maintained (BKNG) at Buy on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Brian Nowak Maintained (BKNG) at Hold on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Thomas Champion Maintained (BKNG) at Hold on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
James Lee Maintained (BKNG) at Strong Buy on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Lloyd Walmsley Maintained (BKNG) at Strong Buy on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Naved Khan Maintained (BKNG) at Strong Buy on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Mario Lu Maintained (BKNG) at Buy on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Ann Duignan Maintained (CAT) at Buy with Increased Target to $237 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Timothy Horan Downgraded (T) to Hold on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Courtney Yakavonis Maintained (SUM) at Hold with Increased Target to $29 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (SWTX) at Strong Buy with Increased Target to $124 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Nigel Dally Maintained (BHF) at Hold with Increased Target to $45 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (VRSK) at Buy with Decreased Target to $216 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Jeffrey Silber Maintained (VRSK) at Hold with Decreased Target to $183 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Jeffrey Maintained (VRSK) at Strong Buy with Decreased Target to $215 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Roger Read Maintained (VLO) at Buy with Increased Target to $99 on, Feb 25th, 2021
[ 12:00 AM ] - WOPRAI
Jeffrey Hung Maintained (ACAD) at Buy with Increased Target to $65 on, Feb 25th, 2021

Jeffrey Hung Maintained (ACAD) at Buy with Increased Target to $65 on, Feb 25th, 2021


Published on 2024-10-27 15:45:48 - WOPRAI, Jeffrey Hung
  Print publication without navigation


Jeffrey Hung of Morgan Stanley, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $60 to $65 on, Feb 25th, 2021.

Jeffrey has made no other calls on ACAD in the last 4 months.



There are 2 other peers that have a rating on ACAD. Out of the 2 peers that are also analyzing ACAD, 0 agree with Jeffrey's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jeffrey

  • Vamil Divan of "Mizuho" Initiated at Strong Buy and Held Target at $69 on, Wednesday, December 16th, 2020
  • Danielle Brill of "Raymond James" Upgraded from Buy to Strong Buy and Held Target at $65 on, Monday, November 16th, 2020
Contributing Sources